GSK3B and cancer: Similarly, miR-19 could exhibit modulatory effect on GSK-3β/β-catenin axis, down-regulated target gene GSK-3β could promote the metastatic potential of lung cancer cells, revealing a poor survival outcome for cancer patients56, 57.